Leading Life Science IT services and software provider, d-wise, an Instem Company, and Vivli are pleased to announce a partnership aimed at providing easily accessible anonymization services and software to leading institutions (biopharmaceutical companies, academic institutions of higher learning) as well as individual researchers planning to share clinical research data on Vivli’s global data sharing platform.
Vivli, is an independent, non-profit organization focused on sharing individual participant-level data from completed clinical trials to serve the international research community. Their platform enables global collaboration and access to data to accelerate scientific insights. Data contributors wishing to share clinical trial data have a responsibility to ensure that trial participants cannot be personally identified. Depending on the size and bandwidth of the organization sharing the data, they may not have a standard method or process for data anonymization in place.
“There are several reasons why sharing clinical research data is important, from global collaboration to moral obligations,” shared Kristin McDougall, Director of Transparency at d-wise. “The go-to partner for many of our clients who proactively share their data is Vivli. d-wise is thrilled to expand into a direct partnership with Vivli so our anonymization software and services can be adopted by a broad, diverse community of stakeholders with a shared goal of advancing human health through the insights and discoveries gained by sharing and analyzing data.”
“We are delighted to partner with d-wise and have them become part of our data sharing community,” said Rebecca Li, Vivli Executive Director. “We believe that together we make it easier for the entire data sharing community to securely share the data from completed clinical trials to advance human health and gain new insights for scientific discovery.”
d-wise offers outsourced anonymization services utilizing industry-leading anonymization software, Blur, allowing sponsors to overcome this hurdle and responsibly share trial data on the Vivli platform while protecting patient data and retaining as much data utility as possible. This empowers pharmaceutical companies to share on a global scale without impacting internal workflows.
This partnership permits both d-wise and Vivli to continue working toward a shared mission to accelerate improvements in human health and wellbeing.
For more information, visit our websites.